Symbol | ETF Name | AUM | Expense Ratio | % Weight in ETF | Market Value | % Weight in ABUS |
|---|---|---|---|---|---|---|
| Virtus LifeSci Biotech Clinical Trials ETF | $37.23M | 0.79% | 0.66% | $238.06K | 0.03% | |
| Invesco NASDAQ Future Gen 200 ETF | $13.87M | 0.20% | 0.43% | $59.61K | <0.01% | |
| Hypatia Women CEO ETF | $7.94M | 0.85% | 0.34% | $27.14K | <0.01% | |
| iShares Micro-Cap ETF | $1.27B | 0.60% | 0.12% | $1.66M | 0.22% | |
| SPDR S&P Kensho New Economies Composite ETF | $2.55B | 0.20% | 0.10% | $2.54M | 0.33% | |
| SPDR S&P BIOTECH ETF | $8.00B | 0.35% | 0.10% | $8.59M | 1.11% | |
| iShares MSCI USA Small-Cap Min Vol Factor ETF | $291.86M | 0.20% | 0.10% | $288.03K | 0.04% | |
| iShares NASDAQ US Biotechnology UCITS ETF | $56.03M | 0.35% | 0.06% | $583.49K | 0.08% | |
| Invesco Nasdaq Biotechnology ETF | $75.35M | 0.19% | 0.06% | $42.76K | <0.01% | |
| Vanguard GlbMomntFac | $359.39M | 0.44% | 0.05% | $153.00K | 0.01% |
